RNA interference screening identifies a novel role for autocrine fibroblast growth factor signaling in neuroblastoma chemoresistance (Q39268126)

10 September 2017

RNA interference screening identifies a novel role for autocrine fibroblast growth factor signaling in neuroblastoma chemoresistance (English)

1 reference

10 September 2017

1 reference

1 reference

0 references

F Salm

1

1 reference

10 September 2017

P Cwiek

2

1 reference

10 September 2017

A Ghosal

3

1 reference

10 September 2017

A Lucia Buccarello

4

1 reference

10 September 2017

F Largey

5

1 reference

10 September 2017

C Wotzkow

6

1 reference

10 September 2017

K Höland

7

1 reference

10 September 2017

B Styp-Rekowska

8

1 reference

10 September 2017

V Djonov

9

1 reference

10 September 2017

I Zlobec

10

1 reference

10 September 2017

N Bodmer

11

1 reference

10 September 2017

N Gross

12

1 reference

10 September 2017

F Westermann

13

1 reference

10 September 2017

S C Schäfer

14

1 reference

10 September 2017

A Arcaro

15

1 reference

10 September 2017

language of work or name

English

0 references

publication date

1 October 2012

1 reference

10 September 2017

1 reference

10 September 2017

32

1 reference

10 September 2017

34

1 reference

10 September 2017

3944-3953

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2012.416

10 September 2017

0 references

cites work

Chemoresistance in solid tumours

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.416

Cisplatin: mode of cytotoxic action and molecular basis of resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.416

The resurgence of platinum-based cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.416

Recent developments in the field of anticancer platinum complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.416

Bcl-2 blocks cisplatin-induced apoptosis and predicts poor outcome following chemoradiation treatment in advanced oropharyngeal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.416

Recent advances in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.416

Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.416

Targeting programmed cell death pathways with experimental therapeutics: opportunities in high-risk neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.416

Sensitized RNAi screen of human kinases and phosphatases identifies new regulators of apoptosis and chemoresistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.416

Identification of CDK10 as an important determinant of resistance to endocrine therapy for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.416

NF1 is a tumor suppressor in neuroblastoma that determines retinoic acid response and disease outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.416

Synergistic effect between erlotinib and MEK inhibitors in KRAS wild-type human pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.416

Drug combination studies and their synergy quantification using the Chou-Talalay method

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.416

An ERK-dependent pathway to Noxa expression regulates apoptosis by platinum-based chemotherapeutic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.416

Fibroblast growth factor signalling: from development to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.416

Molecular cytogenetic characterization of doxorubicin-resistant neuroblastoma cell lines: evidence that acquired multidrug resistance results from a unique large amplification of the 7q21 region

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.416

miRNA expression profiling of the murine TH-MYCN neuroblastoma model reveals similarities with human tumors and identifies novel candidate miRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.416

RNAi screen of the protein kinome identifies checkpoint kinase 1 (CHK1) as a therapeutic target in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.416

Stabilization of N-Myc is a critical function of Aurora A in human neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.416

Inhibition of FGFR2 and FGFR1 increases cisplatin sensitivity in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.416

Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.416

Breast cancer genome-wide association studies: there is strength in numbers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.416

FGFR2 as a molecular target in endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.416

Oncogene mutation profiling of pediatric solid tumors reveals significant subsets of embryonal rhabdomyosarcoma and neuroblastoma with mutated genes in growth signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.416

Synergistic activity of fenretinide and the Bcl-2 family protein inhibitor ABT-737 against human neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.416

BH3 response profiles from neuroblastoma mitochondria predict activity of small molecule Bcl-2 family antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.416

FGF-2 protects small cell lung cancer cells from apoptosis through a complex involving PKCepsilon, B-Raf and S6K2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.416

Fibroblast growth factor-2 induces translational regulation of Bcl-XL and Bcl-2 via a MEK-dependent pathway: correlation with resistance to etoposide-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.416

Roles for NF-kappaB in nerve cell survival, plasticity, and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.416

NF-kappaB signaling in lymphocytes: a new cast of characters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.416

Protein kinase C family functions in B-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.416

Bradykinin-induced IL-6 expression through bradykinin B2 receptor, phospholipase C, protein kinase Cdelta and NF-kappaB pathway in human synovial fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.416

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.416

Enzastaurin, a protein kinase Cbeta- selective inhibitor, and its potential application as an anticancer agent in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.416

A phase I safety study of enzastaurin plus bortezomib in the treatment of relapsed or refractory multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.416

Targeting the phosphoinositide 3-kinase isoform p110delta impairs growth and survival in neuroblastoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.416

A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.416

Two distinct phosphoinositide 3-kinases mediate polypeptide growth factor-stimulated PKB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.416

An overview of real-time quantitative PCR: applications to quantify cytokine gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.416

Customized Oligonucleotide Microarray Gene Expression–Based Classification of Neuroblastoma Patients Outperforms Current Clinical Risk Stratification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.416

Cathepsin D protects human neuroblastoma cells from doxorubicin-induced cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.416

Mcl-1, Vascular Endothelial Growth Factor-R2, and 14-3-3 Expression Might Predict Primary Response against Radiotherapy and Chemotherapy in Patients with Locally Advanced Squamous Cell Carcinomas of the Head and Neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.416

Transcriptional repression of SKP2 is impaired in MYCN-amplified neuroblastoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.416

31 March 2020

Identifiers

DOI

10.1038/ONC.2012.416

1 reference

10 September 2017

1 reference